FILE - The logo for Merck appears above a trading post on the floor of the New York Stock Exchange, Thursday, May 1, 2025. (AP Photo/Richard Drew, File) (Richard Drew ...

Dupixent (dupilumab), a drug already used to treat atopic dermatitis and asthma, became the first biologic approved for chronic obstructive pulmonary disease (COPD) last fall. Most COPD treatments ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma’s new chronic ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Pharmaceutical giant Merck is buying Verona ...